Geron | GERN - Current Assets

Stock Price
1.58
Daily Change
-0.02 -1.25%
Monthly
-12.22%
Yearly
-3.66%
Q1 Forecast
1.53

Geron reported $520.27M in Current Assets for its fiscal quarter ending in December of 2025.





Current Assets Change Date
Amgen USD 29.06B 1.17B Dec/2025
Bio Techne USD 637.43M 27.92M Dec/2025
Cassava Sciences USD 108.91M 5.91M Sep/2025
Cytokinetics USD 916.97M 60.37M Dec/2025
Esperion Therapeutics USD 360.46M 17.87M Sep/2025
Exelixis USD 1.44B 41.03M Dec/2025
Genmab DKK 3.91B 127M Jun/2025
Geron USD 520.27M 2.07M Dec/2025
Gilead Sciences USD 19.89B 1.05B Dec/2025
Incyte USD 5.02B 746.01M Dec/2025
MacroGenics USD 232.09M 27.15M Sep/2025
Novartis USD 28.2B 2.26B Sep/2025
Novavax USD 974.59M 55.08M Sep/2025